Roth MKM analyst Suji Desilva downgraded Ceva to Neutral from Buy with a price target of $20, down from $30, after the company reported Q2 revenue and EPS “well below” consensus. The firm, which sees increased near-term licensing uncertainty, expects shares to remain relatively rangebound in the near-term, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CEVA: